The outcome of Remdesivir and Tocilizumab in COVID 19.
Not Applicable
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
- Registration Number
- CTRI/2021/01/030341
- Lead Sponsor
- Seth G S Medical College and KEM Hospital Mumbai
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Laboratory confirmed COVID 19 adults (Age > 18 years) admitted in KEM Hospital.
2.Patients in ICMR group 2B and onwards.
3.Received any of the following drugs alone or in combination: Remdesivir, Tocilizumab.
Exclusion Criteria
1. Suspected COVID 19 patients.
2. Positive patients in category 1A to 2A
3. Pregnant/Lactating patients.
4. Mortality within 24 hours of admission.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method